---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000050"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-04-19T23:59:59+00:00"
generated_at: "2026-06-03T15:06:38.511336+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Lifecore receives Nasdaq notice for delayed Q3 10-Q; hearing held April 16, decision pending

## Summary
- Nasdaq notice on April 15, 2024, cites continued non-compliance with Listing Rule 5250(c)(1) due to late Q3 10-Q and prior Q1/Q2 filings.
- Company appealed prior Staff Delisting Determination; hearing held April 16, 2024, requesting further stay of suspension/delisting.
- Nasdaq Hearings Panel has not yet issued a decision; no immediate effect on LFCR stock trading.
- Company intends to file overdue reports as promptly as possible but gives no assurance of timeline or panel grant.

## SEC filing metadata
- accession: 0001005286-24-000050
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-04-19T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000050/0001005286-24-000050-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000050/lndc-20240415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000050
- JSON: https://secwatch.observer/filing/0001005286-24-000050.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000050.txt

## Key facts
- Listing & Compliance Notices
  LIFECORE BIOMEDICAL, INC. DE received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: and November 29, 2023 (the “Q1 Form 10-Q” and “Q2 Form 10-Q,” respectively, and together with the Q3 Form 10-Q, the “Filings”) with the Securities and Exchange Commission (the “SEC”), the Company continues not to be in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), and that the Nasdaq Hearings Panel would consider the delinquency in the filing of the Q3 Form 10-Q in rendering its determination regarding the Company’s continued listing on Nasdaq Global Select Market . The Notice has no immediate effect on the listing or trading
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000050/0001005286-24-000050-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.